Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling

BACKGROUND: Clinically, breast cancer is generally classified into estrogen receptor-positive (ER+) or estrogen receptor-negative (ER−) subtypes. The phytoestrogen calycosin has been shown to inhibit the proliferation of ER+ cells, which may be mediated by a feedback loop that involves miR-375, RAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jing, Wang, Yong, Zhang, Xing, Ren, Qianyao, Li, Rong, Huang, Yue, Lu, Huiling, Chen, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667511/
https://www.ncbi.nlm.nih.gov/pubmed/29096683
http://dx.doi.org/10.1186/s13046-017-0625-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667511/
https://www.ncbi.nlm.nih.gov/pubmed/29096683
http://dx.doi.org/10.1186/s13046-017-0625-y

Ejemplares similares